However, landmark NIH-sponsored hypertension trials have clearly demonstrated superiority of the thiazide-like diuretic chlorthalidone (CTD) over ACE-I and CCB in reduction of left ventricle mass (LVM) and prevention of HF. Here, ACE is linked to Hypertension.